1. Home
  2. TRLV vs TYRA Comparison

TRLV vs TYRA Comparison

Compare TRLV & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trulieve Cannabis Corp. Subordinate Voting Shares

TRLV

Trulieve Cannabis Corp. Subordinate Voting Shares

N/A

Current Price

$8.42

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$30.49

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRLV
TYRA
Founded
N/A
2018
Country
United States
Employees
5000
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TRLV
TYRA
Price
$8.42
$30.49
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$47.50
AVG Volume (30 Days)
974.7K
725.7K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.92
$9.96
52 Week High
$10.15
$40.65

Technical Indicators

Market Signals
Indicator
TRLV
TYRA
Relative Strength Index (RSI) 44.02 44.97
Support Level $8.24 $29.68
Resistance Level $9.21 $30.70
Average True Range (ATR) 0.53 1.71
MACD -0.04 -0.21
Stochastic Oscillator 30.00 16.17

Price Performance

Historical Comparison
TRLV
TYRA

About TRLV Trulieve Cannabis Corp. Subordinate Voting Shares

Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: